Harvard Health - How PMOS (once called PCOS) affects women after menopause (Aug 2026)

Tier 1: Established: peer-reviewed research or government health authority
Publisher: Harvard Health Publishing · Published: August 1, 2026 · Accessed: August 18, 2026

Visit the source ↗

Claims this source supports

  • PMOS does not vanish with a woman's reproductive years; the ~10 million women with PMOS in the US continue to face the same symptoms plus ongoing health risks after menopause (Dr. Margaret Lippincott, director of the Multidisciplinary Care Center for Polycystic Ovary Syndrome at Massachusetts General Hospital).
  • For all women, menopause brings a dramatic drop in estrogen and androgens, but for women with PMOS androgen levels may decline only slightly: 'Androgen levels remain higher in postmenopausal women with PMOS than estrogen levels do, so they may still have hair loss on the scalp or notice a mild worsening of hair growth where they don't want it. They may still notice some acne. Those symptoms, hormonally, tend to stay.'
  • Obesity and insulin resistance usually stick around after menopause in PMOS; risks of high blood pressure, high cholesterol, and cardiovascular disease rise significantly.
  • 'Double hit': PMOS with weight struggle or insulin resistance combined with menopause's loss of lean mass and increased mid-body weight distribution, 'both of which are metabolically unfavorable.'
  • Endometrial cancer occurs more often in women with PMOS before and after menopause (history of irregular ovulation and buildup of uterine lining tissue): average woman 1-in-33 risk; women with PMOS about 1 in 11.
  • Dr. Lippincott: 'It's incredibly important that a PMOS diagnosis never falls off the chart for these women.' Management: healthy eating and regular exercise (resistance training improves the body's insulin use), aggressive monitoring (blood sugar, cholesterol, blood pressure; know cholesterol, BMI, hemoglobin A1c), and medications where appropriate (statins, blood pressure drugs, metformin): 'You don't have to power through this on your own.'
  • May 2026 rename context: PCOS renamed PMOS in a JAMA Internal Medicine research letter published online May 11 2026; many of the 170M women worldwide don't have ovarian cysts (excess small antral follicles instead); 'The fact that they've removed the word cyst from the name is actually quite helpful... The new name better reflects what we've known all along' (Dr. Lippincott).